关于我们
B?labs was built by Brandywine Realty Trust and is powered by the Pennsylvania Biotechnology Center (PABC). Our site is a 50,000 SF life science incubator that provides flexible, plug & play lab and research space with a specialized network of resources, programming, and expertise. Addressing the region's intense demand for life science infrastructure, B?labs features newly constructed premier lab space with the latest equipment and technology.
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Philadelphia，Pennsylvania
- 类型
- 私人持股
- 创立
- 2022
- 领域
- Incubator、Accelerator、Drug Discovery、Therapeutics、Venture Capital、Cell Therapy、Gene Therapy和Pharmaceuticals
地点
-
主要
获取路线
2929 Arch St
US，Pennsylvania，Philadelphia，19104
B?labs员工
动态
-
Calling All Artists! We are excited to announce the next chapter in our ongoing series of art installations at B?labs—Beyond the Lens: Art and Science in Dialogue. After previous exhibitions that highlighted the work of local artists, this marks our first thematic collaboration blending the worlds of art and science in a dynamic new way. We’re inviting artists to come together with B?labs residents and explore how these fields can inspire each other through creative collaboration. At our space, we strive to foster a dynamic intersection of community, art, and science. Alongside our new exhibition, we continue to showcase Emily Whitehead's photography and Warrior Art curated by the Emily Whitehead Foundation, which bring the patient voice into the heart of scientific discovery. These works offers a unique perspective, inspiring our environment where scientists are pushing boundaries to create transformative solutions. If you're an artist inspired by scientific concepts this is your opportunity to contribute to an inspiring, cross-disciplinary experience. Selected works will be displayed starting in May 2025 at the B?labs space in the Cira Centre in Philadelphia. The application deadline is March 9, 2025. Space is limited, so apply now! https://lnkd.in/eVbP2MMG
-
-
Go Birds, Go Science! ?? Yesterday, we turned our incubator into a full-blown B?irds Brunch Pep Rally—because if there’s one thing we do best (besides groundbreaking science), it’s repping Philly loud and proud! We went all out with a brunch spread—waffles, eggs, and plenty of green treats to fuel up for game day. From the lab bench to the Linc, this city knows how to hustle—and we’re ALL IN on the Birds bringing that Lombardi back home! LET’S GOOOOO! ??
-
-
What a fantastic event at CYTO | PHL last night, hosted by BioBuzz! The launch of the new BioInnovation Series brought together a great panel, insightful discussions, and a powerful patient perspective from Bradley Watts that truly resonated. Matthew Burkhardt, Director of B?labs, did a fantastic job moderating the panel and leading such an engaging conversation. Hats off to Bryan Kennedy?and BioBuzz for bringing this vision to life—this series is sure to make a lasting impact on the biotech community!
Chief Executive Officer-Hepatitis B Foundation/Blumberg Institute/Pennsylvania Biotechnology Center
Great packed event tonight at CYTO PHL hosted by BioBuzz. The new BioInnovation Series had a great panel and a patient perspective from Bradley Watts that was very impactful. Great job Bryan Kennedy, your vision became a reality!! #biobuzz Bryan Kennedy Brad Watts
-
-
Congrats to the team!
?? Exciting news from Vetigenics! ?? With major progress in our clinical trials and new therapies in the pipeline, we’re taking pet antibody therapeutics to the next level. And with fresh support from our investors, we’re accelerating even faster. See what’s ahead: https://lnkd.in/exkzA7VP #AnimalHealth #Biotech #Vetigenics #PetTherapeutics #AntibodyTherapy #Pets #Dogs #Antibodies #mAbs #ClinicalTrial #Immunotherapy
-
A big congratulations to Dr. High for continuing to move gene therapy programs towards the clinic. Another one to watch for Philadelphia. Article: https://lnkd.in/eWkd_xN3
-
Congrats to the excellent team here.
In 2024, our research team advanced the future of #NeuroResearch by creating ~18,000 miniature brain models, called organoids, from 15 different disease-relevant samples. Through building these models, the lab generated ~1.6 billion cells, which is about 2% of the total cells in a human brain! By studying these organoids, we’re gaining a deeper understanding of how diseases like ALS and Frontotemporal Dementia work and are able to test new treatments and therapies.? We’re excited to build on this progress in 2025 and continue to push the boundaries of what’s possible in neuro research! #Neurology #Research #Neurodegenerative #ALS #FTD #Dementia
-
-
Love to see the increased activity out of Philadelphia across the rare disease landscape. Hugely meaningful work. Congrats to all involved. https://lnkd.in/eXnRG3sy
-
Congrats to University of Pennsylvania Perelman School of Medicine Adj. Prof. Rita Balice-Gordon and the Muna Therapeutics team on the news: https://lnkd.in/eaS2AmYq.